Skip to main content
. 2018 Dec 7;9:5235. doi: 10.1038/s41467-018-07552-9

Fig. 3.

Fig. 3

Clinical and molecular features of cyclin-activated HCC. a t-SNE plots depicting the classification of HCC from the LICA-FR and TCGA cohorts based on their transcriptional profiles. Tumors harboring CCNA2 or CCNE1 activating alterations are indicated with a color code. b Clinical characteristics, driver genes and deregulated pathways associated with CCN-HCC in the LICA-FR (top) and TCGA (bottom) cohorts. c Overall survival in CCN-HCC as compared with other HCC in the LICA-FR cohort. Only HCC with curative resection (R0) were included